Tenapanor Hydrochloride Application Scope

Tenapanor is indicated for the treatment of irritable bowel syndrome with constipation (IBS-C) in adults.

Tenapanor Hydrochloride Characteristics

Ingredients: Active ingredient: Tenapanor hydrochloride
Properties: White to off-white powder; poorly soluble in water; acts locally in the gastrointestinal tract.
Packaging Specification: As indicated on the package.
Storage: Store at room temperature (20–25 °C), protect from moisture and direct light.
Expiry Date: As indicated on the package.
Executive Standard: As indicated on the package.
Approval Number: As indicated on the package.
Date of Revision: As indicated on the package.
Manufacturer: As indicated on the package.

Dosage and Administration:
- Recommended Dose: 50 mg orally, twice daily.
- Administration: Take immediately before the morning and evening meals.
- Missed Dose: If a dose is missed, skip the missed dose and take the next dose at the regular time. Do not double the dose.
Adverse Reactions:
- Common Adverse Reactions: Diarrhea, abdominal distension, flatulence, dizziness.
- Serious Adverse Reactions: Severe diarrhea (may lead to dehydration). Discontinue and seek medical attention if severe diarrhea occurs.
Contraindications:
- Known hypersensitivity to Tenapanor or any excipients.
- Children under 6 years of age (risk of severe dehydration).
- Avoid use in patients with suspected or known mechanical gastrointestinal obstruction.
Precautions:
- Safety not established in pediatric patients under 18 years.
- Use with caution in elderly or patients with severe diarrhea.
- Monitor hydration status in patients at risk of dehydration.

Note:

If there is a new packaging for the drug, the new packaging shall prevail. The above information is sourced from DengYue Medicine.
This content is for reference only. Prescription drugs must be used under a doctor’s guidance and purchased from authorized sources.